NCT03770273 2024-12-17
Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
3 trialsNCT00001756 2022-11-07
Study of Mast Cell Precursors
National Institutes of Health Clinical Center (CC)
Completed
NCT00001760 2007-12-13
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
National Institutes of Health Clinical Center (CC)
Completed